NDC codes

407601 NDC codes with hospital pricing data in the network.

Descriptions:

AI-written plain-English titles; the original text is what hospitals report.

NDC 09999-0117-22 — STUDY CHARGE BIIB017 PEGINTERFERON BETA-1A (PLEGRIDY) 63 MCG/0.5 ML SUBCUTANEOUS PEN (1 hospital, 201 samples)
NDC 09999-0118-40 — STUDY B7981094 RITLECITINIB/PLACEBO 100 MG CAPSULE (WHITE LABEL) (1 hospital, 201 samples)
NDC 09999-0119-03 — STUDY ALTE2131 TRIPTORELIN 22.5 MG INTRAMUSCULAR SUSPENSION (1 hospital, 201 samples)
NDC 09999-0117-21 — STUDY CHARGE BIIB017 PEGINTERFERON BETA-1A (PLEGRIDY) 125 MCG/0.5 ML SUBCUTANEOUS PEN (1 hospital, 201 samples)
NDC 09999-0117-23 — STUDY CHARGE BIIB017 PEGINTERFERON BETA-1A (PLEGRIDY) 94 MCG/0.5 ML SUBCUTANEOUS PEN (1 hospital, 201 samples)
NDC 09999-0097-44 — STUDY A031801-CIRB CABOZANTINIB 20 MG TABLET (1 hospital, 201 samples)
NDC 09999-0118-48 — STUDY R668-EGE-2213 IRB# 22-2246 DUPILUMAB 300 MG/2 ML PREFILLED SYRINGE (1 hospital, 201 samples)
NDC 09999-0098-42 — STUDY RPC-1063-MS-001 OZANIMOD 1 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0104-35 — STUDY NN9389-4606 UNC IRB#21-2634 NNC0480-0389/PLACEBO 30 MG/ML CARTRIDGE (1 hospital, 201 samples)
NDC 09999-0106-60 — STUDY R668-BP-1902 IRB# 22-1408 DUPILUMAB/PLACEBO 300 MG/2 ML PREFILLED SYRINGE (1 hospital, 201 samples)
NDC 09999-0106-07 — STUDY ADRN-12 IRB# 22-1668 DUPILUMAB 300 MG/2 ML SUBCUTANEOUS PREFILLED SYRINGE (1 hospital, 201 samples)
NDC 73177-0127-05 — POTASSIUM CHLORIDE 100 MEQ/50 ML (2 MEQ/ML) IN WATER IV SYRINGE (CONC) (1 hospital, 201 samples)
NDC 09999-0117-65 — STUDY TN-31 ABROCITINIB/PLACEBO 100 MG TABLET (1 hospital, 201 samples)
NDC 09999-0104-34 — STUDY NN9389-4606 UNC IRB#21-2634 NNC0480-0389/PLACEBO 10 MG/ML CARTRIDGE (1 hospital, 201 samples)
NDC 09999-0106-62 — STUDY EVOLVE-MI IRB# 22-1820 EVOLOCUMAB 140 MG/ML SUBCUTANEOUS PEN INJECTOR (1 hospital, 201 samples)
NDC 09999-0099-21 — STUDY R5458-ONC-2012 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION (1 hospital, 201 samples)
NDC 09999-0094-11 — STUDY ALXN1210-NMO-307 RAVULIZUMAB 10 MG/ML INJECTION SOLUTION (1 hospital, 201 samples)
NDC 09999-0099-33 — STUDY A051902-CIRB DUVELISIB 25 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0114-35 — STUDY NCI-10440-CIRB IXAZOMIB 2.3 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0119-94 — STUDY DOC-GBM2 PEGINTERFERON ALFA-2A (PIFN) 180 MCG/0.5 ML INJECTION SYRINGE (1 hospital, 201 samples)
NDC 09999-1991-35 — CEFTOLOZANE-TAZOBACTAM (20 MG OF CEFTOLOZANE/ML) PEDIATRIC INJECTION (1 hospital, 201 samples)
NDC 09999-0113-59 — STUDY LPS17558 IRB# 23-1878 DUPILUMAB 300 MG/2 ML INJECTION (1 hospital, 201 samples)
NDC 09999-0114-36 — STUDY NCI-10440-CIRB IXAZOMIB 3 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0113-58 — STUDY LPS17558 IRB# 23-1878 DUPILUMAB/PLACEBO 300 MG/2 ML INJECTION (1 hospital, 201 samples)
NDC 09999-0113-54 — STUDY R668-EGE-2213 IRB# 22-2246 DUPILUMAB/PLACEBO 300 MG/2 ML PREFILLED SYRINGE (1 hospital, 201 samples)
NDC 09999-0114-37 — STUDY NCI-10440-CIRB IXAZOMIB 4 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0104-32 — STUDY NN9389-4606 UNC IRB#21-2634 SEMAGLUTIDE/PLACEBO 2 MG/1.5 ML (MULTI-DOSE) SUBCUTANEOUS PEN (1 hospital, 201 samples)
NDC 09999-0104-33 — STUDY NN9389-4606 UNC IRB#21-2634 SEMAGLUTIDE/PLACEBO 3.0 MG/ML SUBCUTANEOUS PEN (1 hospital, 201 samples)
NDC 09999-0089-17 — STUDY PNEU-PED V114 VACCINE (1 hospital, 201 samples)
NDC 09999-0099-32 — STUDY A051902-CIRB DUVELISIB 15 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0091-44 — STUDY CX-280-202 CB-280/PLACEBO 50 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0097-45 — STUDY A031801-CIRB CABOZANTINIB 60 MG TABLET (1 hospital, 201 samples)
NDC 09999-0098-41 — STUDY RPC-1063-MS-001 OZANIMOD 0.25 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0118-41 — STUDY B7981094 RITLECITINIB/PLACEBO 50 MG CAPSULE (YELLOW LABEL) (1 hospital, 201 samples)
NDC 09999-0099-20 — STUDY R5458-ONC-2012 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION (1 hospital, 201 samples)
NDC 09999-0080-47 — STUDY NRG-GI004-CIRB ATEZOLIZUMAB 60 MG/ML INTRAVENOUS SOLUTION (1 hospital, 201 samples)
NDC 09999-0117-66 — STUDY TN-31 RITLECITINIB/PLACEBO 100 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0117-95 — STUDY PT217X1101 ATEZOLIZUMAB 60 MG/ML IV SOLUTION (1 hospital, 201 samples)
NDC 09999-0091-45 — STUDY CX-280-202 CB-280/PLACEBO 100 MG CAPSULE (1 hospital, 201 samples)
NDC 09999-0113-62 — STUDY EFC14771 IRB# 23-2814 DUPILUMAB 300 MG/2 ML PRE-FILLED SYRINGE (1 hospital, 201 samples)
NDC 09999-0106-08 — STUDY ADRN-12 IRB# 22-1668 DUPILUMAB 200 MG/1.14 ML SUBCUTANEOUS PREFILLED SYRINGE (1 hospital, 201 samples)
NDC 09999-0117-05 — STUDY M24-064 BEVACIZUMAB 25 MG/ML IV SOLUTION (1 hospital, 201 samples)
NDC 09999-0528-85 — HEPARIN 5,000 UNIT/ML NEBULIZATION (1 hospital, 201 samples)
NDC 36000-0244-25 — Tobramycin injection, 80 mg per 2 mL vialAI (345 hospitals, 20–200 samples)
NDC 51079-0670-05 — Methotrexate 2.5 mg tabletsAI (623 hospitals, 119–200 samples)
NDC 51672-5297-01 — Promethazine 25 mg suppositoryAI (226 hospitals, 20–200 samples)
NDC 51801-0012-30 — Potassium bicarbonate-citric acid effervescent tablets, 20 mEqAI (195 hospitals, 20–200 samples)
NDC 62175-0452-32 — Buprenorphine and naloxone sublingual tabletAI (162 hospitals, 20–200 samples)
NDC 68462-0622-64 — Fosphenytoin sodium injection 500 mg per 10 mLAI (360 hospitals, 20–200 samples)
NDC 63323-0616-02 — Amiodarone hydrochloride intravenous solutionAI (263 hospitals, 20–200 samples)

← PrevPage 660 of 8153Next →